Moser Wealth Advisors’s Novo Nordisk NVO Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $1.09M | Buy |
15,778
+678
| +4% | +$46.8K | 0.52% | 42 |
|
|
2025
Q1 | $1.05M | Buy |
15,100
+1,000
| +7% | +$69.4K | 0.55% | 39 |
|
|
2024
Q4 | $1.21M | Buy |
14,100
+842
| +6% | +$72.4K | 0.63% | 35 |
|
|
2024
Q3 | $1.58M | Buy |
13,258
+1,035
| +8% | +$123K | 0.82% | 32 |
|
|
2024
Q2 | $1.74M | Buy |
12,223
+1,075
| +10% | +$153K | 0.95% | 28 |
|
|
2024
Q1 | $1.43M | Buy |
11,148
+5,610
| +101% | +$720K | 0.8% | 32 |
|
|
2023
Q4 | $573K | Buy |
+5,538
| New | +$573K | 0.37% | 49 |
|
|
2021
Q2 | – | Sell |
-48
| Closed | -$2K | – | 164 |
|
|
2021
Q1 | $2K | Buy |
+48
| New | +$2K | ﹤0.01% | 146 |
|